Spots Global Cancer Trial Database for Diagnostic Study of Early Breast Cancer Using Ultrasound

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Diagnostic Study of Early Breast Cancer Using Ultrasound

Official Title: Microbubble Contrast Ultrasound and Transient Elastography Imaging of Early Breast Cancer

Study ID: NCT01391039

Conditions

Ductal Carcinoma In-situ

Interventions

Perflutren lipid microsphere

Study Description

Brief Summary: This is a pilot study designed to investigate new techniques to guide the appropriate diagnosis and treatment of Ductal Carcinoma In-situ (DCIS). The microvascularity and stiffness of the lesion may be prognostic factors that can guide the need for more or less extensive therapy or perhaps only imaging follow-up may be needed.

Detailed Description: Women who have imaging findings suggestive of DCIS, who are having breast ultrasound and who are candidates for surgery will be eligible. They will receive a contrast-enhanced breast ultrasound after the intravenous injection of a microbubble contrast agent which will show the microvascularity. A subset of women will also have ultrasound elastography performed of the abnormality to evaluate its stiffness.